Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 29
Filter
1.
Rev Esp Patol ; 57(3): 182-189, 2024.
Article in English | MEDLINE | ID: mdl-38971618

ABSTRACT

OBJECTIVE: To test the diagnostic concordance between microscopic (MI) and digital (DG) observation of cervico-vaginal (CV) cytology in a validation study of the technique. METHODS: Five cytotechnologists (CT) reviewed 888 routine CV cytology cases from the Cervical Pathology Unit of our center over a 2-week period of time. The cases were first observed by MI and at the end of the day the cases were observed by DG. STATISTICAL ANALYSIS USED: Agreement calculated using the Kappa index. RESULTS: Most of the diagnoses corresponded to benign (64%) or inflammatory conditions (14%) and 24% corresponded to the intraepithelial lesion or malignancy (ILM) category. The overall kappa coefficient of concordance was strong (0.87). Among the different CTs it was almost perfect in two, strong in two and moderate in one. In 18 cases (10%) there were discrepancies between techniques in the category of ILM. In 10 (56%) cases there was an overdiagnosis in DG and in 8 (44%) an overdiagnosis in MI. Only in two cases, the diagnostic discrepancy exceeded one degree of difference between lesions, and they were ASCUS or AGUS for DG and CIN 2 for MI. CONCLUSIONS: In this validation test in which routine cases during a two-week period have been used, observing the cases with both techniques on the same day, we have obtained a strong degree of concordance. The discordances obtained have not been considered relevant.


Subject(s)
Vaginal Smears , Female , Humans , Cervix Uteri/pathology , Microscopy , Reproducibility of Results , Uterine Cervical Dysplasia/pathology , Uterine Cervical Dysplasia/diagnosis , Uterine Cervical Neoplasms/pathology , Uterine Cervical Neoplasms/diagnosis , Vagina/pathology
2.
Front Neurosci ; 17: 1304440, 2023.
Article in English | MEDLINE | ID: mdl-38144211

ABSTRACT

The brain cortex is the structure that is typically injured in traumatic brain injury (TBI) and is anatomically connected with other brain regions, including the striatum and hypothalamus, which are associated in part with motor function and the regulation of body temperature, respectively. We investigated whether a TBI extending to the striatum could affect peripheral and core temperatures as an indicator of autonomic thermoregulatory function. Moreover, it is unknown whether thermal modulation is accompanied by hypothalamic and cortical monoamine changes in rats with motor function recovery. The animals were allocated into three groups: the sham group (sham), a TBI group with a cortical contusion alone (TBI alone), and a TBI group with an injury extending to the dorsal striatum (TBI + striatal injury). Body temperature and motor deficits were evaluated for 20 days post-injury. On the 3rd and 20th days, rats were euthanized to measure the serotonin (5-HT), noradrenaline (NA), and dopamine (DA) levels using high-performance liquid chromatography (HPLC). We observed that TBI with an injury extending to the dorsal striatum increased core and peripheral temperatures. These changes were accompanied by a sustained motor deficit lasting for 14 days. Furthermore, there were notable increases in NA and 5-HT levels in the brain cortex and hypothalamus both 3 and 20 days after injury. In contrast, rats with TBI alone showed no changes in peripheral temperatures and achieved motor function recovery by the 7th day post-injury. In conclusion, our results suggest that TBI with an injury extending to the dorsal striatum elevates both core and peripheral temperatures, causing a delay in functional recovery and increasing hypothalamic monoamine levels. The aftereffects can be attributed to the injury site and changes to the autonomic thermoregulatory functions.

3.
Integr Comp Biol ; 63(1): 128-135, 2023 Jul 31.
Article in English | MEDLINE | ID: mdl-37204039

ABSTRACT

Public health researchers have long been aware of the importance of defining the human community associated with research on environmental health initiatives. However, the field community's human components where applied ecology research is conducted, e.g. diverse participants and perspectives, are often overlooked in environmental problem solving. We outline a framework for elevating the human dimension in defining the field community in applied ecology research and for teaching diverse undergraduate students the skills needed to address Anthropocene environmental concerns. We promote broadening participation and incorporating cultural and racial perspectives in ecology research planning, implementation, and teaching. We use the environmental research problem of concern to identify the diverse human community groups potentially connected to the problem and guide the strategies for incorporating their perspectives in the proposed research project. Which human community, whether local, ethnic, or visiting public community, affects the resource management strategy, i.e. people protect what they love, can change the outcomes of applied ecological research, as well as promote development of a diverse environmental workforce. Broadening participation and perspectives means that the people asking the research questions are also part of the social ecological community processes who choose which questions to pursue to manage the natural resources of the community. Here, we promote research and teaching practices that consider the long-standing multicultural connections to nature to allow all students to pursue their love of nature and its beauty in a safe, comfortable, and mentoring setting. We integrate current human diversity, equity, and inclusion-focused pedagogical knowledge into the Ecological Society of America-endorsed 4DEE multidimensional curricular framework. We provide a faculty action guide to engage and train diverse students in ecological practices that meet the needs of today's environmental problem-solving workforce.

4.
Neural Regen Res ; 18(4): 875-880, 2023 Apr.
Article in English | MEDLINE | ID: mdl-36204857

ABSTRACT

Norepinephrine plays an important role in motor functional recovery after a brain injury caused by ferrous chloride. Inhibition of norepinephrine release by clonidine is correlated with motor deficits after motor cortex injury. The aim of this study was to analyze the role of α2-adrenergic receptors in the restoration of motor deficits in recovering rats after brain damage. The rats were randomly assigned to the sham and injury groups and then treated with the following pharmacological agents at 3 hours before and 8 hours, 3 days, and 20 days after ferrous chloride-induced cortical injury: saline, clonidine, efaroxan (a selective antagonist of α2-adrenergic receptors) and clonidine + efaroxan. The sensorimotor score, the immunohistochemical staining for α2A-adrenergic receptors, and norepinephrine levels were evaluated. Eight hours post-injury, the sensorimotor score and norepinephrine levels in the locus coeruleus of the injured rats decreased, and these effects were maintained 3 days post-injury. However, 20 days later, clonidine administration diminished norepinephrine levels in the pons compared with the sham group. This effect was accompanied by sensorimotor deficits. These effects were blocked by efaroxan. In conclusion, an increase in α2-adrenergic receptor levels was observed after injury. Clonidine restores motor deficits in rats recovering from cortical injury, an effect that was prevented by efaroxan. The underlying mechanisms involve the stimulation of hypersensitive α2-adrenergic receptors and inhibition of norepinephrine activity in the locus coeruleus. The results of this study suggest that α2 receptor agonists might restore deficits or impede rehabilitation in patients with brain injury, and therefore pharmacological therapies need to be prescribed cautiously to these patients.

6.
Eur J Clin Pharmacol ; 78(2): 287-291, 2022 Feb.
Article in English | MEDLINE | ID: mdl-34664108

ABSTRACT

PURPOSE: To evaluate and compare the efficacy and safety of bevacizumab and aflibercept in second-line treatment in metastatic colorectal cancer (mCRC) in real-life clinical practice. METHODS: Retrospective observational study of patients treated with second-line bevacizumab (BFIR) and aflibercept (AFIR) in mCRC, associated with a FOLFIRI scheme, in the last 12 years (January 2009-January 2021) in a tertiary hospital. Patients with prior oxaliplatin-based treatment were included. VARIABLES MEASURED: previous chemotherapy, treatment time (TT), progression-free survival (PFS), overall survival (OS). To assess toxicity, adverse effects that caused delay in cycle administration were recorded. The lost cycles/month of treatment (CP/MT) were also calculated. RESULTS: Eighty-four patients [40 (47.6%) AFIR and 44 (52.4%) BFIR]. Average age: 60.2 ± 10.7 years. In 79.8% the previous scheme was FOLFOX type. Efficacy of AFIR vs BFIR: median HR of TT (95% CI) = 0.816 (0.527-1.266); p = 0.365, PFS HR (95% CI) = 0.674 (0.389-1.117); p = 0.159, OS HR (95% CI) = 0.566 (0.342-0.936); p = 0.026. The main reason for the delay in administration was neutropenia (28.7% AFIR vs 24.7% BFIR), and the greatest difference found was thrombopenia (13.9% AFIR vs 2.5% BFIR), without observing large differences between the rest of adverse reactions. Mean CP/MT: 0.49 ± 0.46 cycles with AFIR and 0.33 ± 0.27 with BFIR; p = 0.046. CONCLUSION: Although no statistically significant differences have been found in TT or PFS, it would be more advisable to use BFIR scheme due to its better results in OS and toxicity profile.


RESUMEN: OBJETIVO: Evaluar y comparar la eficacia y seguridad de bevacizumab y aflibercept en segunda línea de tratamiento en el cáncer colorrectal metastásico (CCRm) en la práctica clínica real. MéTODOS: Estudio observacional retrospectivo de los pacientes tratados con bevacizumab (BFIR) y aflibercept (AFIR) en segunda línea en CCRm, asociado a un esquema FOLFIRI, en los últimos 12 años (septiembre 2009-enero 2021) en un hospital de tercer nivel. Se incluyeron pacientes con tratamiento previo basado en oxaliplatino. Variables medidas: esquema previo, tiempo de tratamiento (TT), supervivencia libre de progresión (SLP), supervivencia global (SG). Para valorar toxicidad, se registraron los efectos adversos que provocaron retraso en la administración del ciclo. También se calcularon los ciclos perdidos/mes de tratamiento (CP/MT). RESULTADOS: 84 pacientes [40 (47,6%) AFIR y 44 (52,4%) BFIR]. Media de edad: 60,2 ± 10,7 años. En el 79,8% el esquema previo fue tipo FOLFOX. Eficacia de AFIR vs BFIR: HR de mediana de TT (IC95%) = 0,816 (0,527­1,266); p = 0,365, HR de SLP (IC95%) = 0,674 (0,389­1,117); p = 0,159, HR de SG (IC95%) = 0,566 (0,342­0,936); p = 0,026. El principal motivo de retraso en la administración fue neutropenia (28,7% AFIR vs 24,7% BFIR), y el que más diferencia hubo entre ambos la trombopenia (13,9% AFIR vs 2,5% BFIR), sin observarse grandes diferencias entre el resto de reacciones adversas. Media de CP/MT: 0,49 ± 0,46 ciclos con AFIR y 0,33 ± 0,27 con BFIR; p = 0,046. CONCLUSIONES: Aunque no se han encontrado diferencias estadísticamente significativas en TT ni en SLP, sería más recomendable utilizar el esquema BFIR por sus mejores resultados en SG y perfil de toxicidad.


Subject(s)
Bevacizumab/therapeutic use , Colorectal Neoplasms/drug therapy , Receptors, Vascular Endothelial Growth Factor/therapeutic use , Recombinant Fusion Proteins/therapeutic use , Aged , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Bevacizumab/administration & dosage , Bevacizumab/adverse effects , Colorectal Neoplasms/pathology , Female , Fluorouracil/therapeutic use , Humans , Leucovorin/therapeutic use , Male , Middle Aged , Neoplasm Metastasis , Organoplatinum Compounds/therapeutic use , Progression-Free Survival , Receptors, Vascular Endothelial Growth Factor/administration & dosage , Recombinant Fusion Proteins/administration & dosage , Recombinant Fusion Proteins/adverse effects , Retrospective Studies
7.
Neurochem Res ; 46(12): 3179-3189, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34387812

ABSTRACT

Brain injury leads to an excitatory phase followed by an inhibitory phase in the brain. The clinical sequelae caused by cerebral injury seem to be a response to remote functional inhibition of cerebral nuclei located far from the motor cortex but anatomically related to the injury site. It appears that such functional inhibition is mediated by an increase in lipid peroxidation (LP). To test this hypothesis, we report data from 80 rats that were allocated to the following groups: the sham group (n = 40), in which rats received an intracortical infusion of artificial cerebrospinal fluid (CSF); the injury group (n = 20), in which rats received CSF containing ferrous chloride (FeCl2, 50 mM); and the recovery group (n = 20), in which rats were injured and allowed to recover. Beam-walking, sensorimotor and spontaneous motor activity tests were performed to evaluate motor performance after injury. Lipid fluorescent products (LFPs) were measured in the pons. The total pontine contents of glutamate (GLU), glutamine (GLN) and gamma-aminobutyric acid (GABA) were also measured. In injured rats, the motor deficits, LFPs and total GABA and GLN contents in the pons were increased, while the GLU level was decreased. In contrast, in recovering rats, none of the studied variables were significantly different from those in sham rats. Thus, motor impairment after cortical injury seems to be mediated by an inhibitory pontine response, and functional recovery may result from a pontine restoration of the GLN-GLU-GABA cycle, while LP may be a primary mechanism leading to remote pontine inhibition after cortical injury.


Subject(s)
Brain Injuries/physiopathology , Glutamic Acid/metabolism , Glutamine/metabolism , Motor Cortex/physiology , Pons/metabolism , Recovery of Function , gamma-Aminobutyric Acid/metabolism , Animals , Lipid Peroxidation , Male , Motor Disorders/physiopathology , Oxidative Stress , Rats , Rats, Wistar
8.
Ecol Appl ; 31(6): e02348, 2021 09.
Article in English | MEDLINE | ID: mdl-34181297

ABSTRACT

How do students discover ecology? Answering this question is essential for diversifying the environmental workforce because scientific disciplines, such as ecology, are often not discovered until students enter academia and are exposed to different disciplinary options. Ecology, and many of the environmental sciences, have persistent and alarmingly low numbers of underrepresented minorities (URM; African American, Hispanic American, Native American, and Pacific Islanders), while other science and technology fields have shown progress in diversification. Why does such underrepresentation persist in environmental disciplines? Social factors such as sense of belonging, science identity, implicit biases, and stereotypes all have been explored and are known to influence the participation of URM students in science. The unique role of the field experience in environmental sciences as a "rite of passage" and "authentic" research experience is one important influence on how URM students experience ecology. Interventions using social elements such as belonging and sense of place are demonstrated ways to broaden participation particularly in environmental science fields, yet dramatic underrepresentation still persists. Here we review known factors affecting and enhancing the recruitment and retention of URMs in the sciences and focus on comprehensive strategies shown to be effective recruiting URM students into the environmental workforce.


Subject(s)
Minority Groups , Students , Humans
9.
Trends Ecol Evol ; 36(4): 269-273, 2021 04.
Article in English | MEDLINE | ID: mdl-33483170

ABSTRACT

Ecological research includes social-ecological-evolutionary processes, but the intersectionality and feedbacks between ecology and environmental justice (EJ) remain low. We here present opportunities for ecological research contributions to EJ. Ultimately, such work can reduce racial and social disparities in environmental provisioning and improve global environmental sustainability.

10.
Cartilage ; 13(1_suppl): 1074S-1084S, 2021 12.
Article in English | MEDLINE | ID: mdl-32406246

ABSTRACT

Objective. To evaluate minimum biosecurity parameters (MBP) for arthroscopic matrix-encapsulated autologous chondrocyte implantation (AMECI) based on patients' clinical outcomes, magnetic resonance imaging (MRI) T2-mapping, Magnetic Resonance Observation of Cartilage Repair Tissue (MOCART) score, and International Cartilage Repair Society (ICRS) second-look arthroscopic evaluation, laying the basis for a future multicenter study. Design. Pilot clinical study. We analyzed the logistics to perform AMECI to treat focal chondral lesions in different hospitals following strict biosecurity parameters related to tissue and construct transportation, chondrocyte isolation, and cell expansion. Patient progress was analyzed with patient-reported outcome measures, MRI T2-mapping, MOCART, and ICRS arthroscopic second-look evaluation. Results. Thirty-five lesions in 30 patients treated in 7 different hospitals were evaluated. Cell viability before implantation was >90%. Cell viability in construct remnants was 87% ± 11% at 24 hours, 75% ± 17.1% at 48 hours, and 60% ± 8% at 72 hours after implantation. Mean final follow-up was 37 months (12-72 months). Patients showed statistically significant improvement in all clinical scores and MOCART evaluations. MRI T2-mapping evaluation showed significant decrease in relaxation time from 61.2 ± 14.3 to 42.9 ± 7.2 ms (P < 0.05). Arthroscopic second-look evaluation showed grade II "near normal" tissue in 83% of patients. Two treatment failures were documented. Conclusions. It was feasible to perform AMECI in 7 different institutions in a large metropolitan area following our biosecurity measures without any implant-related complication. Treated patients showed improvement in clinical, MRI T2-mapping, and MOCART scores, as well as a low failure rate and a favorable ICRS arthroscopic evaluation at a mid-term follow-up. Level of Evidence. 2b.


Subject(s)
Cartilage, Articular , Chondrocytes , Cartilage, Articular/diagnostic imaging , Cartilage, Articular/surgery , Follow-Up Studies , Humans , Latin America , Transplantation, Autologous/methods
11.
Cartilage ; 13(1_suppl): 197S-207S, 2021 12.
Article in English | MEDLINE | ID: mdl-31387368

ABSTRACT

BACKGROUND: Complex meniscal lesions often require meniscectomy with favorable results in the short term but a high risk of early osteoarthritis subsequently. Partial meniscectomy treated with meniscal substitutes may delay articular cartilage degeneration. PURPOSE: To evaluate the status of articular cartilage by T2 mapping after meniscal substitution with polyurethane scaffolds enriched with mesenchymal stem cells (MSC) and comparison with acellular scaffolds at 12 months. METHODS: Seventeen patients (18-50 years) with past meniscectomies were enrolled in 2 groups: (1) acellular polyurethane scaffold (APS) or (2) polyurethane scaffold enriched with MSC (MPS). Patients in the MPS group received filgrastim to stimulate MSC production, and CD90+ cells were obtained and cultured in the polyurethane scaffold. The scaffolds were implanted arthroscopically into partial meniscus defects. Concomitant injuries (articular cartilage lesions or cartilage lesions) were treated during the same procedure. Changes in the quality of articular cartilage were evaluated with T2 mapping in femur and tibia at 12 months. RESULTS: In tibial T2 mapping, values for the MPS group increased slightly at 9 months but returned to initial values at 12 months (P > 0.05). In the APS group, a clear decrease from 3 months to 12 months was observed (P > 0.05). This difference tended to be significantly lower in the APS group compared with the MPS group at the final time point (P = 0.18). In the femur, a slight increase in the MPS group (47.8 ± 3.4) compared with the APS group (45.3 ± 4.9) was observed (P > 0.05). CONCLUSION: Meniscal substitution with polyurethane scaffold maintains normal T2 mapping values in adjacent cartilage at 12 months. The addition of MSC did not show any advantage in the protection of articular cartilage over acellular scaffolds (P > 0.05).


Subject(s)
Cartilage, Articular , Knee Injuries/surgery , Mesenchymal Stem Cell Transplantation , Mesenchymal Stem Cells , Osteoarthritis, Knee , Polyurethanes/chemistry , Tibial Meniscus Injuries/therapy , Tissue Scaffolds , Adolescent , Adult , Cartilage, Articular/surgery , Cartilage, Articular/transplantation , Female , Humans , Male , Meniscectomy , Meniscus/surgery , Middle Aged , Osteoarthritis, Knee/surgery , Tissue Engineering , Treatment Outcome , Young Adult
12.
Ecol Appl ; 30(8): e02250, 2020 12.
Article in English | MEDLINE | ID: mdl-33170978

ABSTRACT

Environmental injustice can be expressed through lack of access to resources, unequal exposure to toxins, and limited access to knowledge about the unsustainable environmental practices that impact communities (Bullard 2018). The ecological processes that contribute to the "perfect storm" of conditions that create environmental injustices are well documented in applied ecology scholarship; yet the human dimension or the co-production of research on those impacts seem to fall into the range of "somebody else's problem." In a literature review of the last 15 years of research published in the Ecological Society of America's family of journals, we explored the intersections of environmental processes and social justice issues, searching for themes, gaps, and opportunities. The resultant is a collection of articles on environmental justice topics that includes issues on access to resources and unequal exposure to environmental hazards and pollutants. This collection highlights gaps in the integration of natural science with social justice topics along with the need for stronger integration of interdisciplinary knowledge that is co-produced with community stakeholders and researchers to build a robust interdisciplinary field of climate justice and global environmental sustainability.


Subject(s)
Environmental Pollutants , Social Justice , Ecology , Humans
14.
CNS Neurol Disord Drug Targets ; 19(2): 148-162, 2020.
Article in English | MEDLINE | ID: mdl-32303175

ABSTRACT

BACKGROUND: Parkinson's Disease (PD) is a common neurodegenerative disorder affecting the dopaminergic (DAergic) system. Replacement therapy is a promising alternative aimed at reconstructing the cytoarchitecture of affected brain regions in PD. Experimental approaches, such as the replacement of DAergic neurons with cells obtained from the Enteric Nervous System (ENS) has yet to be explored. OBJECTIVE: To establish and characterize a cell replacement strategy with ENS Cells (ENSCs) in a PD model in rats. METHODS: Since ENSCs can develop mature DAergic phenotypes, here we cultured undifferentiated cells from the myenteric plexus of newborn rats, establishing that they exhibit multipotential characteristics. These cells were characterized and further implanted in the Substantia nigra pars compacta (SNpc) of adult rats previously lesioned by a retrograde degenerative model produced by intrastriatal injection of 6-Hydroxydopamine (6-OHDA). DAergic markers were assessed in implants to validate their viability and possible differentiation once implanted. RESULTS: Cell cultures were viable, exhibited stem cell features and remained partially undifferentiated until the time of implant. The retrograde lesion induced by 6-OHDA produced DAergic denervation, reducing the number of fibers and cells in the SNpc. Implantation of ENSCs in the SNpc of 6-OHDAlesioned rats was tracked after 5 and 10 days post-implant. During that time, the implant increased selective neuronal and DAergic markers, Including Microtubule-Associated Protein 2 (MAP-2), Dopamine Transporter (DAT), and Tyrosine Hydroxylase (TH). CONCLUSION: Our novel results suggest that ENSCs possess a differentiating, proliferative and restorative potential that may offer therapeutic modalities to attenuate neurodegenerative events with the inherent demise of DAergic neurons.


Subject(s)
Dopaminergic Neurons/metabolism , Neural Stem Cells/transplantation , Parkinson Disease/therapy , Stem Cell Transplantation/methods , Animals , Disease Models, Animal , Dopamine/metabolism , Enteric Nervous System , Male , Oxidopamine/metabolism , Rats , Rats, Sprague-Dawley , Tyrosine 3-Monooxygenase/metabolism
15.
J Pediatr Gastroenterol Nutr ; 71(1): 59-63, 2020 07.
Article in English | MEDLINE | ID: mdl-32044834

ABSTRACT

OBJECTIVES: The aim of the study was to describe diagnostic criteria used in children with coeliac disease (CD) and selective IgA deficiency; to determine if the publication of the 2012 ESPGHAN criteria prompted any changes; to evaluate the evolution of serological markers. METHODS: Multicenter, retrospective, descriptive study of a cohort of children under 15 years with selective IgA deficiency diagnosed with CD (January 2006 to December 2016). Demographic, clinical, genetic, histological and IgG-based antibodies were collected at diagnosis and follow-up. RESULTS: Eighty-six children were included, 60 diagnosed after the guide. Two groups were established: G1 (n = 63) and G2 (n = 23) with or without diagnostic biopsy respectively. In G1: 87.3% were symptomatic, 87.3% had human leukocyte antigan (HLA) DQ2/DQ8 typing (all positive), all had IgG serology positive (71.5% ATG, 35% EMA, 19% DPG, 9.5% AGA), and all had villous atrophy (Marsh-Oberhuber 2-3). Follow-up data were available in 58 children, 34 after 2 years on a gluten-free diet. Fifty-two percentage remained ATG IgG-positive despite good dietary adherence and symptom remission. Regarding G2: all were diagnosed post-2012, had typical symptoms, HLA DQ2/DQ8 positive and ATG IgG × 10 ULN. Additionally, EMA IgG was performed in 14 (60%), all positive. CONCLUSIONS: In our cohort of children with selective IgA deficiency and diagnosed with CD, children without a diagnostic biopsy suggests that IgG serology was considered the equivalent as IgA isotype, even when this is not addressed in the aforementioned guidelines. Great heterogeneity was observed in the IgG serology used at diagnosis. After 2 years of a gluten-free diet, half of children remained with a positive serology.


Subject(s)
Celiac Disease , IgA Deficiency , Autoantibodies , Biopsy , Celiac Disease/diagnosis , Child , Follow-Up Studies , Humans , IgA Deficiency/complications , IgA Deficiency/diagnosis , Immunoglobulin A , Retrospective Studies , Transglutaminases
19.
Biomed Pharmacother ; 88: 745-753, 2017 Apr.
Article in English | MEDLINE | ID: mdl-28157650

ABSTRACT

BACKGROUND: URB597 is a compound largely linked to the inhibition of fatty acid amide hydrolase (FAAH), an enzyme responsible for the metabolic degradation of the endocannabinoid anandamide (AEA). Despite this pharmacological property accounts for its modulatory profile demonstrated in some neurotoxic paradigms, the possible protective properties of this agent have been poorly investigated, and deserve exploration in different neurotoxic models. In this study, we explored the effects of URB597 on oxidative damage to lipids and other major endpoints of toxicity in two neurotoxic models in vivo in rats (the first one produced by the mitochondrial neurotoxin 3-nitropropionic acid [3-NP], and the other generated by the striatal injection of the pro-oxidant toxin 6-hydroxidopamine [6-OHDA]) in order to provide further supporting evidence of its modulatory profile. METHODS: Male Wistar adult rats were treated for 5 or 7 consecutive days with URB597 (0.3mg/kg, i.p.) and simultaneously exposed to three injections of 3-NP (30mg/kg, i.p.) or a single intrastriatal infusion of 6-OHDA (0.02mg/2µl), respectively. Twenty four hours after all treatments were administered, lipid peroxidation was measured in the striatum of 3-NP-treated rats, and in the midbrain of 6-OHDA-treated rats. Motor skills and histological assessment in the striatum were also evaluated in 3-NP-treated rats 6 and 7days after the last drug administration, respectively; whereas apomorphine-induced circling behavior and tyrosine hydroxylase immunolocalization in the striatum and substantia nigra were investigated 21 and 22days after the last drug infusion, respectively. RESULTS: URB597 prevented the oxidative damage to lipids induced by 3-NP in the striatum, and this effect could account for the attenuation of motor deficits in this model. Attenuation of motor disturbances induced by URB597 in both models was associated with the morphological preservation of the striatum in the 3-NP model and the partial preservation of tyrosine hydroxylase in the 6-OHDA model in the SNpc and striatum. CONCLUSION: The modulatory actions exerted by URB597 in both toxic models support its potential against toxic conditions implying motor and neurochemical alterations linked to energy depletion, excitotoxicity and oxidative stress. Although most of these effects could be attributable to its action on FAAH and further AEA accumulation, in light of our present findings other properties are suggested.


Subject(s)
Benzamides/therapeutic use , Carbamates/therapeutic use , Neuroprotective Agents/therapeutic use , Neurotoxicity Syndromes/drug therapy , Amidohydrolases/antagonists & inhibitors , Animals , Apomorphine , Behavior, Animal/drug effects , Body Weight/drug effects , Injections , Lipid Peroxidation/drug effects , Male , Motor Skills/drug effects , Neostriatum , Neurotoxicity Syndromes/pathology , Neurotoxicity Syndromes/psychology , Nitro Compounds , Oxidopamine , Propionates , Rats , Rats, Wistar
20.
Rev. senol. patol. mamar. (Ed. impr.) ; 28(2): 66-72, abr.-jun. 2015. ilus, tab
Article in Spanish | IBECS | ID: ibc-135530

ABSTRACT

Objetivo: La citología líquida (CL) permite estudiar la muestra mejor preservada y con menos artefactos que la citología convencional (CC). El objetivo de este estudio es evaluar los resultados de la técnica de CL en un periodo de un año desde su implantación en nuestro laboratorio. Pacientes y métodos: Se comparan los resultados de una serie de 1.573 punciones de mama con CL realizadas en un año y 3.033 con CC en 2 años, con los hallazgos en las biopsias cuando se dispuso de estos. Resultados: Los diagnósticos obtenidos en CL fueron: insuficiente en 208 (13,2%) casos, benigno en 1.160 (73,7%), hiperplasia en 70 (4,5%), sospechoso en 45 (2,9%) y maligno en 90 (5,7%). En 264 casos (17%) de CL existió correlación histológica. La concordancia en el diagnóstico de benignidad fue del 74%, en hiperplasia del 75% y en malignidad del 92%. En la serie de CC hubo correlación en 350 casos (11%), la concordancia en el diagnóstico de benignidad fue del 80%, en hiperplasia del 81% y en malignidad del 92%. La sensibilidad diagnóstica de la CC fue del 78%, la especificidad del 95%, el valor predictivo positivo del 94% y el valor predictivo negativo del 79%. La sensibilidad de la CL fue del 85%, la especificidad del 91%, el valor predictivo positivo del 87% y el valor predictivo negativo del 89%. Conclusión: La CL disminuye el número de diagnósticos insuficientes pero incrementa el de hiperplasia y sospechosos. La eficacia en el diagnóstico de malignidad entre ambas técnicas es similar (AU)


Objective: Liquid-based cytology (LBC) improves specimen preservation and produces fewer artefacts than conventional cytology (CC). The objective of this study was to evaluate the results of LBC in our laboratory after one year of its use. Patients and methods: The results of a series of 1,573 biopsy specimens prepared with LBC in a one-year period were compared with a series of 3,033 specimens prepared with CC in a 2-year period and with histological features, when available. Results: The diagnoses obtained with LBC were insufficient in 208 (13.2%) cases, benign in 1,160 (73.7%), hyperplasia in 70 (4.5%), suspicious in 45 (2.9%) and malignancy in 90 (5.7%). A histological correlation with the diagnosis was obtained in 264 LBC samples (17%). The concordance was 74% in the diagnosis of benign lesions, 75% in hyperplasia, and 92% in malignant lesions. In the CC series, there was correlation in 350 samples (11%). The concordance was 80% in the diagnosis of benign disease, 81% in hyperplasia, and 91% in malignant disease. The diagnostic sensitivity of CC in malignant disease was 78%, specificity was 95%, positive predictive value was 94%, and negative predictive value was 79%. The sensitivity of LBC in malignant disease was 85%, specificity was 91%, positive predictive value was 87%, and negative predictive value was 89%. Conclusion: LBC decreases the number of insufficient samples but increases diagnosis of hyperplasia and suspicious lesions. Efficacy in the diagnosis of malignancy is similar between the 2 techniques (AU)


Subject(s)
Humans , Female , Biopsy, Fine-Needle/methods , Breast Neoplasms/pathology , Cytological Techniques/methods , Sensitivity and Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...